Image of Gail H Cassell

Gail H Cassell, Ph.D.

Dr. Cassell is vice president for TB Drug Development at the Infectious Disease Research Institute in Seattle, Washington, professor emeritus and former chair, Department of Microbiology, University of Alabama at Birmingham, and former vice president for scientific affairs and distinguished Lilly research scholar for infectious diseases at Eli Lilly and Company in Indianapolis, Indiana. She founded the Forum on Drug Discovery, Development and Translation, which she continues to co-chair, at the Institute of Medicine. She has a distinguished record of national service with the National Academy of Sciences, National Institutes of Health, Centers for Disease Control, and several other national and international institutions.

Affiliations:

Division of Global Health Equity, Brigham and Women's Hospital

Dr. Cassell is a leader on efforts to address multidrug-resistant tuberculosis (MDRTB). She and Barry Bloom, former dean of Harvard School of Public Health, co-lead an Institute of Medicine project on drug supply chain issues related to MDRTB. She actively advises numerous government agencies, NGOs, and foundations on the scale-up of MDRTB diagnosis and treatment in endemic areas around the world, including in Russia. Dr. Cassell is advising the GHSM Sentinel Project on pediatric drug-resistant tuberculosis, a global partnership that aims to develop and deploy evidence-based strategies to prevent child deaths from drug-resistant tuberculosis.

Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: a prospective study.
Authors: Authors: Stagno S, Brasfield DM, Brown MB, Cassell GH, Pifer LL, Whitley RJ, Tiller RE.
Pediatrics
View full abstract on Pubmed
Detection of Mycoplasma pulmonis antibody in rats and mice by a rapid micro enzyme linked immunosorbent assay.
Authors: Authors: Mia AS, Kravcak DM, Cassell GH.
Lab Anim Sci
View full abstract on Pubmed
Mycoplasma host-cell interactions resulting in chronic inflammation: acquisition of host antigens and other mechanisms.
Authors: Authors: Davis JK, Cassell GH, Minion FC, Wise KS.
Isr J Med Sci
View full abstract on Pubmed
Adherence and colonization of Mycoplasma pulmonis to genital epithelium and spermatozoa in rats.
Authors: Authors: Cassell GH, Wilborn WH, Silvers SH, Minion FC.
Isr J Med Sci
View full abstract on Pubmed
Arthritis of rats and mice: implications for man.
Authors: Authors: Cassell GH, Davis JK, Lindsey JR, Cole BC, Hartley MW.
Isr J Med Sci
View full abstract on Pubmed
Control of Mycoplasma pulmonis infection in rats and mice: detection and elimination vs. vaccination.
Authors: Authors: Cassell GH, Davis JK, Lindsey JR.
Isr J Med Sci
View full abstract on Pubmed
Respiratory and genital mycoplasmosis of laboratory rodents: implications for biomedical research.
Authors: Authors: Cassell GH, Lindsey JR, Davis JK.
Isr J Med Sci
View full abstract on Pubmed
Attachment of mycoplasmas to erythrocytes: a model to study mycoplasma attachment to the epithelium of the host respiratory tract.
Authors: Authors: Kahane I, Pnini S, Banai M, Baseman JB, Cassell GH, Bredt W.
Isr J Med Sci
View full abstract on Pubmed
Mycoplasmas as agents of human disease.
Authors: Authors: Cassell GH, Cole BC.
N Engl J Med
View full abstract on Pubmed
Interactions between murine alveolar macrophages and Mycoplasma pulmonis in vitro.
Authors: Authors: Davis JK, Delozier KM, Asa DK, Minion FC, Cassell GH.
Infect Immun
View full abstract on Pubmed